Stock·NYSE·Industrials
Trane Technologies (TT)
- Market cap
- $100.12B
- P/E
- 33.91
- Dividend yield
- 0.90%
- Street target
- $536.00median of 26 analysts
- 52-week range
- $348.06 $505.87
TT stock forecast today
Where TT stands today, and what CleaRank Financial AI makes of it.
TT at a glance
Trane Technologies (TT): Buy, 64/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($452.41 and $453.85).
- Earnings TT beat estimates in 7 of the 7 reports in our data, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $90.0M and bought $172K over the last 18 months.
- Valuation P/E of 33.9 against 34.0 for the Industrials sector: broadly in line with peers (0%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Trane Technologies (TT) Buy, with a model score of 64/100.
The analysts' outlook lifts the score most: 17 of 26 analysts rate it a buy and the median target is 17.8% above the price. The trend is up: TT trades 0.58% above its 50-day average of $452.41 and 0.26% above its 200-day average of $453.85. Over the past year the price rose 6.85%.
Only on CleaRank
Figures we compute ourselves from TT's own price, earnings and insider-filing history. Tap one to see it in context.
TT stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $455.03 is 0.6% above the 50-day simple moving average of $452.41.Price above its 200-day average ›
The price is 0.3% above the 200-day simple moving average of $453.85.50-day average above the 200-day ›
The 50-day average ($452.41) is 0.3% below the 200-day average ($453.85), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 68% of its 52-week range, between $348.06 and $505.87.
TT share price
Pick a period: each tab shows how far TT has moved over it, to the last close.
Today's trading
Where TT sits inside today's range and its 52-week range.
TT fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 33.91 is 0.3% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 4.47 is 11.6% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $3.0B on revenue of $22.2B, a net margin of 13.5%.Beat estimates in most recent reports ›
TT beat the EPS estimate in 7 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 0.90%, or $4.09 a share a year.
Key statistics
The headline figures for TT.
As of October 26, 2026, TT trades at $455.03, with a market value of $100.12B, a P/E ratio of 33.91 and a dividend yield of 0.90%.
What the numbers say
CleaRank Financial AI's reading of TT's valuation, growth and risks.
Trane Technologies (TT) trades on a trailing P/E of 33.91, which is 0.3% below the Industrials median of 34.0; the peer comparison on this page rates that multiple as broadly in line with peers. To put the P/E in context, trailing earnings are $13.42 per share.
Growth trails the sector: revenue grew 10.60% in the latest quarter year on year, against a sector median of 11.7%. Profitability shows a net margin of 13.28% and an operating margin of 19.25%, with a return on equity of 36.64%, above the sector median of 17.8%. Rounding out the fundamentals, TT reports debt-to-equity of 0.53 and a trailing dividend yield of 0.90% ($4.09 a share a year).
TT's most recent earnings report, released on July 30, 2026, topped the estimate by 1.17%: EPS came in at $4.31 against the $4.26 analysts had forecast. Investors responded positively, and the stock rose 3.33% in the following session.
The record is a clean sweep: 7 beats in 7 reports, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Looking ahead, analysts expect EPS of $15.28 this fiscal year (growth of 17.0%) and $17.66 the year after (growth of 15.6%).
Daily price swings are the main risk to plan for. TT moves 1.63% on an average session, and its beta against the S&P 500 is 1.16. Over the last 18 months, insiders sold $90.0M of stock and bought $172K. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they carry less weight than open-market purchases.
TT against the Industrials sector
How TT compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (0% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 14, 2025, TT has gained 8.4% against a gain of 18.8% for XLI.
Performance against XLI
TT and the Industrials sector fund over the same days.
Revenue and earnings
How much TT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 7.5% in FY2025 to $21.3B, from $19.8B a year earlier.
Profit margin: The net margin was 13.8% in FY2025, up from 13.1% the year before.
Profitable: TT earned $2.9B in FY2025.
Earnings reality check
Did TT beat what analysts expected, and how did the stock react?
Earnings record: TT beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | $4.26 | $4.31 | +1.17% | +3.33% | +8.72% |
| Apr 30, 2026after close | $2.53 | $2.63 | +3.95% | -1.23% | -4.61% |
| Oct 30, 2025after close | $3.78 | $3.88 | +2.65% | +0.51% | -2.41% |
| Jul 30, 2025after close | $3.79 | $3.88 | +2.37% | +1.54% | -1.02% |
| Apr 30, 2025after close | $2.20 | $2.45 | +11.36% | +2.43% | +6.24% |
| Jan 30, 2025after close | $2.54 | $2.61 | +2.76% | -0.97% | -2.35% |
| Oct 30, 2024after close | $3.24 | $3.37 | +4.01% | -1.43% | +4.35% |
As of October 26, 2026, TT has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on July 30, 2026, came in 1.17% above the estimate and the stock moved +3.33% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
TT AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 48.0, in neutral territory.RSI above 50 ›
An RSI of 48.0 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of TT
The score, the reasoning behind it, and what could move the price next.
Trane Technologies (TT) is in an uptrend: the price of $455.03 sits 0.26% above its 200-day average of $453.85 and 0.58% above its 50-day average of $452.41. The 50-day average is 0.32% below the 200-day average, a sign that the recovery has yet to lift the longer-run averages. Over the past year, the price is 30.73% above the 52-week low of $348.06 and 10.05% below the 52-week high of $505.87.
Short-term and long-term readings disagree. Over the past month the price climbed 0.13%, yet over the past three months it slid 5.86%, and over the past year it gained 6.85%. Momentum sits in the neutral zone with a 14-day RSI of 48.0, while the MACD line is positive.
Earnings beat ›
The July 30, 2026 report beat the EPS estimate by 1.17%, and the share price rose 3.33% in the first session after it.
Source: Earnings report, July 30, 2026Analyst upgrade ›
Goldman Sachs upgraded it to Buy from Neutral on October 14, 2026.
Source: Analyst action, Goldman Sachs, October 14, 2026
New analyst coverage ›
JP Morgan restarted coverage at Overweight on October 9, 2026.
Source: Analyst action, JP Morgan, October 9, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $459.21 sits above the price, and the 200-day SMA at $453.85 sits below it.
- The 14-day RSI is 48.0, which is in the neutral zone, and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- In the first session after the July 30, 2026 report, the share price climbed 3.33%. TT has beaten estimates in 7 of the 7 reports in our data.
TT's uptrend depends on the price holding above its 50-day average of $452.41 and its 200-day average of $453.85. A close below the 200-day would be the first sign of that trend cracking. If the price pulls back, the first level it would reach is the 200-day SMA at $453.85.
The first level above the price is the 20-day EMA, at $459.21.
Technical indicators
Momentum and trend for TT, from its daily closes.
As of October 26, 2026, with TT at $455.03, its 14-day RSI is 48.0 (neutral territory), its 50-day simple moving average is $452.41 and its 200-day is $453.85.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What TT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, TT's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.56 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.18 with gold (XAU).
TT price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
17 of 26 analysts rate it a buy or strong buy, 8 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $536.00 is 17.8% above the price.More buy ratings than three months ago ›
17 of 26 rate it a buy now, against 13 of 24 three months ago.
TT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 15, 2026 | Mizuho | Maintains | Neutral |
| Oct 14, 2026 | Goldman Sachs | Upgrade | Buy |
| Oct 14, 2026 | RBC Capital | Maintains | Sector Perform |
| Oct 9, 2026 | JP Morgan | Reinstates | Overweight |
| Sep 25, 2026 | Wells Fargo | Initiates | Overweight |
| Aug 14, 2026 | Bernstein | Maintains | Outperform |
As of October 26, 2026, 26 Wall Street analysts cover TT: 17 rate it a buy or strong buy, 8 a hold and 1 a sell or strong sell. Their 12-month price targets range from $422.00 to $575.00. The median TT price target is $536.00, 17.8% above the price of $455.03.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
TT trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
TT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from TT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much TT tends to move, against the market and on its own.
TT price history and drawdowns
TT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.63% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 38.0%, from December 2021 to June 2022, regained by August 2023.Most 1-year holds ended higher ›
85% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $101,880, against $42,015 in the S&P 500 (SPY).
TT Drawdowns & Recovery
As of October 26, 2026, TT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -38.0% (December 2021 to June 2022); it regained that peak by August 2023, 14 months after the low, and 85% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into TT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: TT beat the S&P 500 over this period: $101,880 against $42,015.
A $10,000 investment in TT in October 2016 would be worth about $101,880 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to TT, and which have not.
Strongest month, November: an average of +8.15%, up in 8 of 10 years.
Weakest month, March: an average of -2.65%, up in 5 of 10 years.
This month, October: has averaged +0.72%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, TT's strongest calendar month has been November (average +8.15%, up in 8 of 10 years) and its weakest March (average -2.65%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
TT stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in TT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in TT today could grow to about $15,084 by 2030 in the base case, with a 90th-percentile outcome near $30,551 and a 10th-percentile outcome around $7,447. The simulation models price only; at today's 0.90% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
TT Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $686 for TT by 2030 in the base case, from $455 today (1.5x over 4 years). The 10th-percentile path ends near $339. These are outcomes of a Monte Carlo simulation run on TT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $354 | $504 | $718 | |
| 2028 | $339 | $559 | $921 | |
| 2029 | $336 | $619 | $1,141 | |
| 2030 | $339 | $686 | $1,390 |
Method: a lognormal simulation of TT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
TT insider trading
What the people running the company have bought and sold.
TT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $172K on the open market and sold $90.0M.
As of October 26, 2026, TT insiders reported 21 open-market sales worth $90.0M and 1 open-market purchase worth $172K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 48.1K | $23.1M |
| Oct 6, 2026 | David S Regnery
Chief Executive Officer
|
Option | 48.1K | $3.8M |
| Aug 5, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 43.8K | $20.8M |
| Aug 5, 2026 | David S Regnery
Chief Executive Officer
|
Option | 43.8K | $3.1M |
| Aug 4, 2026 | Melissa N Schaeffer
Director
|
Sell | 145 | $68.5K |
| Jul 1, 2026 | Donald E Simmons
Chief Operating Officer
|
Grant | 826 | - |
| Jun 5, 2026 | Kirk E Arnold
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Ann C Berzin
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Jesus Assis Ana Paula De
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Mark R. George
Director
|
Grant | 438 | - |
| Jun 5, 2026 | John A Hayes
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Myles P Lee
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Boise April Miller
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Matthew Francis Pine
Director
|
Grant | 438 | - |
| Jun 5, 2026 | Melissa N Schaeffer
Director
|
Grant | 438 | - |
| Jun 5, 2026 | John P Surma Jr.
Director
|
Grant | 438 | - |
| Apr 30, 2026 | Donald E Simmons
Officer
|
Sell | 4.6K | $2.3M |
| Apr 30, 2026 | Donald E Simmons
Officer
|
Option | 4.6K | $828.8K |
| Apr 8, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Sell | 8.6K | $3.9M |
| Mar 6, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 36.0K | $15.2M |
| Mar 6, 2026 | Donald E Simmons
Officer
|
Sell | 3.8K | $1.6M |
| Mar 6, 2026 | Elizabeth A Elwell
Officer
|
Sell | 635 | $268.4K |
| Mar 5, 2026 | John A Hayes
Director
|
Buy | 400 | $172.2K |
| Mar 4, 2026 | Elizabeth A Elwell
Officer
|
Grant | 888 | - |
| Mar 4, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 15.2K | - |
| Mar 4, 2026 | Mairead Magner
Officer
|
Grant | 4.3K | - |
| Mar 4, 2026 | David S Regnery
Chief Executive Officer
|
Grant | 63.7K | - |
| Mar 4, 2026 | Donald E Simmons
Officer
|
Grant | 6.7K | - |
| Feb 12, 2026 | Donald E Simmons
Officer
|
Sell | 7.7K | $3.6M |
| Feb 12, 2026 | Donald E Simmons
Officer
|
Option | 7.7K | $1.3M |
| Feb 10, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 5.6K | $2.6M |
| Feb 10, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Sell | 2.4K | $1.1M |
| Feb 10, 2026 | Donald E Simmons
Officer
|
Sell | 822 | $380.2K |
| Feb 10, 2026 | Elizabeth A Elwell
Officer
|
Sell | 137 | $63.4K |
| Feb 6, 2026 | David S Regnery
Chief Executive Officer
|
Sell | 987 | $445.2K |
| Feb 6, 2026 | Donald E Simmons
Officer
|
Sell | 439 | $198.1K |
| Feb 6, 2026 | Elizabeth A Elwell
Officer
|
Sell | 46 | $20.8K |
| Feb 3, 2026 | Mauro Atalla
Officer
|
Grant | 977 | - |
| Feb 3, 2026 | Elizabeth A Elwell
Officer
|
Grant | 230 | - |
| Feb 3, 2026 | Mingxiao Gary Guo
Officer
|
Grant | 919 | - |
| Feb 3, 2026 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 2.7K | - |
| Feb 3, 2026 | Victoria Viviane Lazar
Officer
|
Grant | 919 | - |
| Feb 3, 2026 | Mairead Magner
Officer
|
Grant | 862 | - |
| Feb 3, 2026 | David S Regnery
Chief Executive Officer
|
Grant | 8.3K | - |
| Feb 3, 2026 | Donald E Simmons
Officer
|
Grant | 2.0K | - |
| Dec 4, 2025 | Mingxiao Gary Guo
Officer
|
Grant | 5.9K | - |
| Oct 30, 2025 | Elizabeth A Elwell
Officer
|
Sell | 600 | $264.0K |
| Oct 30, 2025 | Elizabeth A Elwell
Officer
|
Option | 600 | $47.4K |
| Oct 1, 2025 | Elizabeth A Elwell
Officer
|
Sell | 401 | $170.4K |
| Oct 1, 2025 | Elizabeth A Elwell
Officer
|
Option | 401 | $28.2K |
| Sep 2, 2025 | David S Regnery
Chief Executive Officer
|
Sell | 22.5K | $9.2M |
| Sep 2, 2025 | David S Regnery
Chief Executive Officer
|
Option | 22.5K | $1.4M |
| Aug 20, 2025 | Christopher J Kuehn
Chief Financial Officer
|
Grant | 300 | - |
| Jun 5, 2025 | Kirk E Arnold
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Ann C Berzin
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Jesus Assis Ana Paula De
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Mark R. George
Director
|
Grant | 465 | - |
| Jun 5, 2025 | John A Hayes
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Linda P Hudson
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Myles P Lee
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Boise April Miller
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Matthew Francis Pine
Director
|
Grant | 465 | - |
| Jun 5, 2025 | Melissa N Schaeffer
Director
|
Grant | 465 | - |
| Jun 5, 2025 | John P Surma Jr.
Director
|
Grant | 465 | - |
| May 2, 2025 | Donald E Simmons
Officer
|
Sell | 8.4K | $3.4M |
| May 2, 2025 | Donald E Simmons
Officer
|
Option | 8.4K | $1.3M |
| Apr 30, 2025 | Donald E Simmons
Officer
|
Sell | 3.6K | $1.4M |
| Apr 30, 2025 | Donald E Simmons
Officer
|
Option | 3.6K | $376.0K |
Source: TwelveData, from reported insider filings
TT stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.